- Targeting natural antioxidant polyphenols to protect neuroinflammation and neurodegenerative diseases: a comprehensive review
- Glycosphingolipids in neurodegeneration - Molecular mechanisms, cellular roles, and therapeutic perspectives
- Huntington's Disease in Hospitalized Patients Infected with SARS-CoV-2 in Brazil: Three-Year Update
- Neuroimaging Techniques in Huntington's Disease: A Critical Review
- Anxiety, memory, and social impairments in the YAC128 mouse model of Huntington's disease
- Upcoming meetings related to Huntington's disease
- Absence of hippocampal pathology persists in the Q175DN mouse model of Huntington's disease despite elevated HTT aggregation
- Antidopaminergic medications in Huntington's disease
- Exploring relationships among gait, balance, and physical activity in individuals with Huntington's disease
- Advances in Molecular Docking Techniques for Targeting Protein Misfolding in Neurodegenerative Diseases
- Are people living with Huntington's disease experiencing person-centered integrated care?
- Economic burden of Huntington's disease: A systematic review
- Huntington's Disease Clinical Trials Update: September 2024
- Mortality trends and disparities in adults with Huntington's disease in the United States
- Through their eyes: A retrospective mixed-methods study on the experiences and support needs of children growing up with a parent with Huntington's disease
- Study protocol for the iMarkHD study in individuals with Huntington's disease
- Sleep-wake cycle and 24-h motor activity in early-mid Huntington's disease patients: An actigraphy-based study
- Frequency of depression in Huntington's disease: A systematic review and meta-analysis
- Huntington's disease at work: The effect of profession-specific requirements as related to clinical characteristics on work outcome
- Optogenetic restoration of neuron subtype-specific cortical activity ameliorates motor deficits in Huntington's Disease mice
- Social cognition profile in early Huntington disease: Insight from neuropsychological assessment and structural neuroimaging
- Quality of care through the eyes of residents with Huntington's disease living in a nursing home: A qualitative explorative study
- Comparative analysis of neurofilament light chain in Huntington's disease like 2 and Huntington's disease
- Acceptance and commitment therapy with Huntington's disease: A narrative review and case report of a caregiver-assisted intervention
- Cognitive impairment in Huntington's disease and its impact on functioning: Concept elicitation and cognitive debriefing for the Huntington's Disease Everyday Functioning (Hi-DEF) scale
- CellFIE: Integrating Pathway Discovery With Pooled Profiling of Perturbations Uncovers Pathways of Huntington's Disease, Including Genetic Modifiers of Neuronal Development and Morphology
- PYK2 in the dorsal striatum of Huntington's disease R6/2 mouse model
- Healthcare delay in neurogenetic disorders of adult onset and the role of predictive genetic testing
- A narrative review of phase III and IV clinical trials for the pharmacological treatment of Huntington's disease in adults
- Navigating competing needs: a qualitative study on parenthood with a partner with Huntington's disease
- Hyperthermia and targeting heat shock proteins: innovative approaches for neurodegenerative disorders and Long COVID
- Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology
- Unbiased human genomic characterization of polyglutamine disorder genes to inform therapeutic strategies
- MTH1 in the disorders of the central nervous system: scope beyond brain tumors and challenges
- Treating incurable non-communicable diseases by targeting iron metabolism and ferroptosis
- Evaluating Determinants of Length of Stay in Burn Care: Is One Day per 1% Total Burn Surface Area Still Accurate?
- Tracing the evolution and genomic dynamics of mating-type loci in Cryptococcus pathogens and closely related species
- The roles of intrinsically disordered proteins in neurodegeneration
- Intercellular communication via exosomes: A new paradigm in the pathophysiology of neurodegenerative disorders
- Dental Calculus Formation Rate: The Role of Salivary Proteome and Metaproteome
- Evaluation of GFM1 mutations pathogenicity through in silico tools, RNA sequencing and mitophagy pahtway in GFM1 knockout cells
- Social cognition in basal ganglia pathologies: Theory of Mind in Huntington's and Parkinson's diseases
- Vectors in CRISPR Gene Editing for Neurological Disorders: Challenges and Opportunities
- Regulation of the structural dynamics, aggregation, and pathogenicity of polyQ-expanded Huntingtin by osmolytes
- Leucine 7 is a key residue for mutant huntingtin induced mitochondrial pathology and neurotoxicity in Huntington's disease
- The Huntington's disease drug pipeline: a review of small molecules and their therapeutic targets
- Home cage-based insights into motor learning and strategy adaptation in a Huntington disease mouse model
- An in vivo platform to screen for regulators of Huntington's disease
- Multimer Detection System: A Universal Assay System for Differentiating Protein Oligomers from Monomers
- Multi-functional role of apolipoprotein E in neurodegenerative diseases
- Ubiquitin-Proteasome-Mediated Protein Degradation and Disorders of the Central Nervous System
- Distinct mismatch-repair complex genes set neuronal CAG-repeat expansion rate to drive selective pathogenesis in HD mice
- The Antioxidant Role of Aromatic Plant Extracts in Managing Neurodegenerative Diseases: A Comprehensive Review
- Antisense oligonucleotide-mediated MSH3 suppression reduces somatic CAG repeat expansion in Huntington's disease iPSC-derived striatal neurons
- Correction to: Advances in gene and cellular therapeutic approaches for Huntington's disease
- Multimodal Anesthesia-Analgesia for Patients with Huntington's Disease: A Case Series
- Neurotrophins as Potential Gene Therapy Targets for Huntington's Disease
- Accelerated epigenetic aging in Huntington's disease involves polycomb repressive complex 1
- A randomized clinical trial to evaluate the efficacy of cognitive rehabilitation and music therapy in mild cognitive impairment in Huntington's disease
- AMPA receptor diffusional trapping machinery as an early therapeutic target in neurodegenerative and neuropsychiatric disorders
- The expanded Bostrychia moritziana genome unveils evolution in the most diverse and complex order of red algae
- Elucidating the Neuroprotective Potential of Arbutin in 3-NPA induced HD-like Pathology: Insights from In Silico, In Vitro, and In Vivo Models
- Customizable virus-like particles deliver CRISPR-Cas9 ribonucleoprotein for effective ocular neovascular and Huntington's disease gene therapy
- Refining Ligand Poses in RNA/Ligand Complexes of Pharmaceutical Relevance: A Perspective by QM/MM Simulations and NMR Measurements
- Burns, Aging, and Appalachia: The Untold Story of Hospital Stays
- Peripheral and central elevation of IL-8 in patients with Huntington's disease
- Characterization of visual cognition in pre-manifest, manifest and reduced penetrance Huntington's disease
- Synaptic plasticity and neuroprotection: The molecular impact of flavonoids on neurodegenerative disease progression
- Optogenetic restoration of neuron subtype-specific cortical activity ameliorates motor deficits in Huntington's Disease mice
- Exosomes in Regulating miRNAs for Biomarkers of Neurodegenerative Disorders
- Formation of amyloid-like HTTex1 aggregates in neurons, downregulation of synaptic proteins and early mortality of Huntington's disease flies are causally linked
- Somatic CAG-repeat expansion drives neuronal loss in Huntington's disease
- Peroxisome proliferator-activated receptors (PPARs) agonists as promising neurotherapeutics
- Lack of Evidence for Kynurenine Pathway Dysfunction in Huntington's Disease: CSF and Plasma Analyses from the HDClarity Study
- Mapping Longitudinal Psychiatric Signatures in Huntington's Disease
- Elucidating cortical neurovascular involvement in Huntington's disease using human brain tissue microarrays
- The Huntingtin Transport Complex
- Noninvasive Brain Stimulation as Focal Epilepsy Treatment in the Hospital, Clinic, and Home
- A PA-led telemedicine advance care planning intervention in a life-limiting illness
- Glutamine missense suppressor transfer RNAs inhibit polyglutamine aggregation
- Revised Diagnostic Criteria for Huntington Disease: What's It Gonna Take?
- Huntingtin inclusion bodies have distinct immunophenotypes and ubiquitination profiles in the Huntington's disease human cerebral cortex
- Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases
- Pharmacological Treatment of Neuropsychiatric Symptoms in Huntington's Disease: A Systematic Review
- Serum neurofilament light chain but not serum glial fibrillary acidic protein is a marker of early Huntington's disease
- The effects of ursodeoxycholic acid on Parkinson's disease, a mechanistic review of the recent evidence
- Exploring immunotherapeutic strategies for neurodegenerative diseases: a focus on Huntington's disease and Prion diseases
- Structural insights into substrate transport and drug inhibition of the human vesicular monoamine transporter 2 (VMAT2)
- Application of Anti-Motion Ultra-Fast Quantitative MRI in Neurological Disorder Imaging: Insights From Huntington's Disease
- Chemical exchange saturation transfer MRI for neurodegenerative diseases: an update on clinical and preclinical studies
- Psychiatric Symptoms Among Adolescents and Young Adults With or Without the Huntingtin Gene Expansion
- An examination of criminal offenders with dementia in Australian courts
- Estrogen-related receptor gamma is a regulator of mitochondrial, autophagy, and immediate-early gene programs in spiny projection neurons: Relevance for transcriptional changes in Huntington disease
- Predictive testing for Huntington's disease in a digital age; patient power with potential pitfalls
- Modeling and correction of protein conformational disease in iPSC-derived neurons through personalized base editing
- Brain Age as a New Measure of Disease Stratification in Huntington's Disease
- Common alterations to astrocytes across neurodegenerative disorders
- Development and testing the psychometric properties of 20 bolt-on items for the EQ-5D-5L across 31 rare diseases
- Racial Disparities in Time to Huntington Disease Diagnosis in North America: An ENROLL-HD Analysis
- Chaperones as Potential Pharmacological Targets for Treating Protein Aggregation Illness
RSS Feed – Literature
HDinHD > RSS Feed – Literature
